Regencell Bioscience Holdings Limited
RGC
$12.80
$0.241.91%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.96M | 7.96M | 4.80M | 4.80M | 11.56M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 152.80K | 152.80K | -- | -- | 56.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 5.03M | 5.03M | -- |
| Total Current Assets | 8.11M | 8.11M | 9.83M | 9.83M | 11.62M |
|
|
|||||
| Total Current Assets | 8.11M | 8.11M | 9.83M | 9.83M | 11.62M |
| Net Property, Plant & Equipment | 226.50K | 226.50K | -- | -- | 891.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 97.70K | 97.70K | 642.40K | 642.40K | 108.50K |
| Total Assets | 8.44M | 8.44M | 10.48M | 10.48M | 12.62M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 125.30K | 125.30K | -- | -- | 158.10K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 59.80K | 59.80K | -- | -- | 438.30K |
| Total Finance Division Other Current Liabilities | 8.40K | 8.40K | -- | -- | 10.60K |
| Total Other Current Liabilities | 8.40K | 8.40K | -- | -- | 10.60K |
| Total Current Liabilities | 193.60K | 193.60K | -- | -- | 606.90K |
|
|
|||||
| Total Current Liabilities | 193.60K | 193.60K | -- | -- | 606.90K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.90K | 25.90K | -- | -- | 25.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 312.60K | 312.60K | -- |
| Total Liabilities | 219.50K | 219.50K | 312.60K | 312.60K | 632.30K |
|
|
|||||
| Common Stock & APIC | 29.88M | 29.88M | 10.16M | 10.16M | 29.43M |
| Retained Earnings | -21.62M | -21.62M | -- | -- | -17.32M |
| Treasury Stock & Other | -45.80K | -45.80K | -- | -- | -86.70K |
| Total Common Equity | 8.22M | 8.22M | 10.16M | 10.16M | 12.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.22M | 8.22M | 10.16M | 10.16M | 12.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -40.90K |
| Total Equity | 8.22M | 8.22M | 10.16M | 10.16M | 11.99M |
|
|
|||||